Professional Documents
Culture Documents
Presentation Outline
Aetiology Brief Overview of Pathophysiology How to make a diagnosis of Asthma
Aetiology of Asthma
Genetic . Single nucleotide polymorphism in 17 q 21. Environmental. Respiratory tract viral infections increase the
risk in children, Stress and drugs like beta blockers. Maternal tobacco smoking during pregnancy. Socio-economic factors, see Hygiene Hypothesis
Factors enhancing Th1 activation: - reduce Th2 activity - decrease frequency of allergic diseases and asthma.
Hypothesis supported by: - Epidemiologic evidence reduced frequency of allergy or asthma in those exposed to: Mycobacterium tuberculosis, measles, hepatitis A virus. Asthma more prevalent among affluent societies.
Aetiology Continued
Asthma is defined as chronic inflammation of the airways that is
characterized by increased responsiveness of the tracheobronchial tree to a multiplicity of stimuli. Allergic/atopic/early onset asthma---rhinitis, Urticaria , eczema ,(+)skin tests , Ig E,(+) response to provocation tests with aeroallergens.
Idiosyncratic/non-atopic/late onset asthma--- no allergic
diseases,(-)skin tests, normal Ig E, symptoms when upper resp infection, sx last days or months.
Pathophysiology of Asthma
1.Early bronchospastic response- type1reaction within min after inhalation( IH) of AG:
Mechanism: IH of aeroallergen sensitization
formation of IgE & expression on mast cells re-exposure to AG mast cell degranulation & mediator release bronchospasm
Pathophysiology
2.Late-bronchospastic reaction: in 30-50%, 6-10 hours after AG exposure. Minority only a late response
Mechanism: recruitment of E, N, L and macrophages
release lipid mediators (PG E2, F2 ,D2; LT C,D,E , PAF), O2radicals, toxic granule proteins, cytokines (TH1:IL-2, IFN; TH2: IL-4, IL-5) bronchoconstriction, vascular congestion, mucosal edema, mucus production, mucociliary transport.
blockers Environment pollution ozone,SO2, NO2 Occupational- metal salts, biological enzymes Infection- resp viruses Exercise IH cold dry air thermally-induced hyperemia and micro-vascular engorgement Emotional stress
History
Chest tightness Cough Sputum
Breathlessness
Family history of asthma, eczema, rhinitis SYMPTOMS ARE EPISODIC AND VARIABLE
Allergens
Cigarette smoke Drugs
Investigations
FBC Sputum Chest X-ray
Procedures
Pulmonary function testing Metacholine and histamine challenge Exercise testing
of the following; i. Wheeze ii. Breathlessness iii. Chest tightness iv. Cough. Especially if symptoms are worse at night or precipitated by known asthma triggers. Other clinical features include; i. History of atopic disorder ii. Family history of asthma iii. Wide spread wheeze on auscultation. iv. Otherwise unexplained low peripheral blood eosinophilia
Classification of Severity
Severity in patients 12 years of age [15] Symptom frequency Night time symptoms %FEV1 of predicted FEV1 Variability Use of shortacting beta2 agonist for symptom control 2 days per week
Intermittent
2 per week
2 per month
80% 80%
<20% 2030%
Mild persistent
Moderate persistent Severe persistent
34 per month
>1 per week but not nightly Frequent (often 7/week)
6080%
>30%
<60%
>30%
"Normal" PaCO2
no improvement Add ipratropium bromide 0.5mg 4-6 hourly if there is poor response to nebulised salbutamol Prednisolone 40-60 mg daily for 14 days or until recovery. Give IV if unable to swallow but efficacy is the same. Give the following if there is no response; i. IV Magnesium 1.2-2g over 20 minutes ii. Adrenaline sc 0.1 mg repeated hourly 2-3 iii. Ketamine /Inhalational anaesthetics in ICU NB: IV aminophyline is no longer recommended as studies have not shown any benefits.
severity. Achieve early control Maintain control by; by stepping up as necessary and stepping down when control is good. Complete control is defined as ; no daytime symptoms, no night awakening due to asthma, no exacerbations, no exercise limitation, minimal side effects from medication, and PEF >80% of the predicted.
schedules. When to start controller drugs? relievers used 2d/week. or 2x night time awakenings.
mcg/day, start at a dose appropriate to severity of disease. Unequal benefits in individuals: Cigarette smoking, neutrophillic
inflammation, pharmacogenetics.
Side effects -local, prevention measures.
Management continued
Give either of the following if no response to the above; IV Magnesium sulphate 1.2-2g over 20 minutes Adrenaline 0.1mg sc every 30 minutes for 2-3 times.
fails.
LTRA
control. Maintain the high dose of inhaled steroid at 2000 mcg/day. Educate patients on avoiding triggers , adherence and when to seek immediate care.